Background NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…

We conducted a prospective study among women in Mombasa, Kenya, to determine
whether Trichomonas vaginalis infection was associated with an increased risk of human …

To determine whether recommendations of infectious diseases specialists affect outcome
for patients, we evaluated 244 hospitalized patients with Staphylococcus aureus bacteremia. …

Background Bacterial vaginosis (BV) is the most common vaginal infection among women
of reproductive age and is associated with important adverse health outcomes. Estimates of …

We investigated the effect of human immunodeficiency virus type 1 (HIV-1) subtype on
disease progression among 145 Kenyan women followed from the time of HIV-1 acquisition. …

Background: The role of homosexuality and anal sex practices in the African HIV-1 epidemic
is not well described. We aimed to assess the risk factors for prevalent HIV-1 infection …

… Assuming a proportional hazards model (seqDesign in R) with 80% power to detect 75%
efficacy, a sample size of 2250 participants was planned. … Scott McClelland, MD, MPH …

Background Observational studies of a putative association between hormonal contraception
(HC) and HIV acquisition have produced conflicting results. We conducted an individual …

To assess the effect of treatment of vaginal infections on vaginal shedding of cell-free
human immunodeficiency virus type 1 (HIV-1) and HIV-1–infected cells, HIV-1–seropositive …

The determinants of a broad neutralizing antibody (NAb) response and its effect on human
immunodeficiency virus type 1 (HIV-1) disease progression are not well defined, partly …